New Horizons – Current GIST Treatment Options
Dr. Jonathan Noujaim and Dr. Yoon-Koo Kang presented an update to "Current GIST Treatments" at New Horizons 2021.
New Horizons – Global Access to Treatment
Dr. Sameer Rastogi and Dr. Yoon-Koo Kang presented "Global Access to Treatment" at New Horizons 2021.
New Horizons – Best Practices: How to Advocate for Better Access
Sarah McGoram, Carolina Goič, Florence Thwagi, Tania Carolina Diaz presented Best Practices: How to Advocate for Better Access at New Horizons 2021.
New Horizons – GIST Research Updates
Dr. Ciara Kelly, Dr. Suzanne George, and Dr. Bruno Vincenzi presented GIST Research Updates at New Horizons 2021.
New Horizons – SDH-deficient GIST Research Update
Dr. Shruti Bhargava, University of California San Diego, presented SDH-deficient GIST Research Updates at New Horizons 2021.
New Horizons – Using Real World Evidence to Impact Future Clinical Trials
Pete Knox of The Life Raft Group presented Using Real World Evidence to Impact Future Clinical Trials and Improve Patient Survival: A Focus on Placebos at New Horizons 2021.
A Conversation with a Few of Our Global GIST Mentors
n June 2021, we trained seven LRG members from Austria, Canada, Chile, India, and Singapore. LRG’s Global GIST Mentors are survivors or caregivers who volunteer their time, energy, and talent to support others.
Conversations with the LRG: International GIST Mentors
On Thursday, October 7th at 2pm ET the LRG held “Conversations with the LRG". In this presentation, our Global GIST Mentors discussed the role of the GIST Mentor and how one can assist you on your GIST journey.
Australian GIST Advocates Overcome Payer Obstacles Concerning Qinlock
Australian GIST Advocates Overcome Payer Obstacles Concerning Qinlock. 4th line drug approval was approved! GISTer Sarah McGoram shares the news.
Actualización realizada por dos prestigiosos especialistas internacionales en GIST
Publicado por Colectivo GIST España - Concluimos el mes dedicado a la concienciación del sarcoma & GIST publicando una actualización del tratamiento para los tumores GIST avanzados.